Table of Contents
Cover
Cover | |
Contents
Contents | |
150-151 |
From the Editor
Patient autonomy or patient confusion? | |
Bridget Farham | 152 |
Editor's choice
Editor's Choice | |
Janet Seggie | 153 |
Correspondence
Reducing the surgical complications of smoking by cotinine testing | |
D J Potgieter, G dos Passos, C E Price, A D Rogers | 154-155 |
A path to full-service contracting with general practitioners under National Health Insurance | |
Shabir Moosa | 155-156 |
Primary prevention of rheumatic fever in children: Key factors to consider | |
Andrew Steer, Margie Danchin, James H Irlam, Bongani M Mayosi, Mark E Engel, Thomas A Gaziano, Andrew C Whitelaw | 156-157 |
A balanced approach to interpreting the WHIRCDMT | |
Patrick B Wilson | 157-158 |
Izindaba
From coal-face clinicians to change agents – igniting healthcare innovation | |
159-160 |
Annually, 1% of gold miners die – 4% sent home sick | |
160-162 |
Obituaries
Hymie Gaylis | |
Norman Albert Blumberg | 163 |
Dennis James Pudifin | |
Yackoob Kassim Seedat | 163 |
Forum
Clinical Access Program for Bedaquiline for the treatment of drug-resistant tuberculosis | |
Francesca Conradie, Graeme Meintjes, Jennifer Hughes, Gary Maartens, Hannetjie Ferreira, Sweetness Siwendu, Iqbal Master, Norbert Ndjeka | 164-166 |
Recommendations pertaining to the use of viral vaccines: Influenza 2014 | |
S Walaza | 166-167 |
Cardiovascular prevention: Lifestyle and statins – competitors or companions? | |
Lionel Henry Opie, Anthony John Dalby | 168-173 |
Isoniazid preventive therapy for tuberculosis in South Africa: An assessment of the local evidence base | |
Robin Wood, Linda-Gail Bekker | 174-177 |
The research ethics evolution: From Nuremberg to Helsinki | |
Ames Dhai | 178-180 |
Editorial
New imaging approaches for improving diagnosis of childhood tuberculosis | |
Sabine Bélard, Savvas Andronikou, Tanyia Pillay, Martin P Grobusch, Heather J Zar | 181-182 |
Research
Systematic review of the evidence for rational dosing of colistin | |
E Visser Kift, G Maaartens, C Bamford | 183-186 |
Determinants, outcomes and costs of ceftriaxone v. amoxicillin-clavulanate in the treatment of community-acquired pneumonia at Witbank Hospital | |
S N Xaba, O Greeff, P Becker | 187-191 |
The impact of chronic pseudomonal infection on pulmonary function testing in individuals with cystic fibrosis in Pretoria, South Africa | |
A Pentz, P Becker, R Masekela, O Coetzee, R J Green | 191-194 |
Cardiometabolic markers to identify cardiovascular disease risk in HIV-infected black South Africans | |
J M van Rooyen, C M T Fourie, H S Steyn, G Koekemoer, H W Huisman, R Schutte, L Malan, M Glyn, W Smith, C Mels, A E Schutte | 195-199 |
High pleural fluid adenosine deaminase levels: A valuable tool for rapid diagnosis of pleural TB in a middle-income country with a high TB/HIV burden | |
C P Onyenekwu, A E Zemlin, R T Erasmus | 200-203 |
Integration of TB and ART services fails to improve TB treatment outcomes: Comparison of ART/TB primary healthcare services in Cape Town, South Africa | |
R Kaplan, J Caldwell, L-G Bekker, K Jennings, C Lombard, D A Enarson, R Wood, N Beyers | 204-209 |
Tuberculosis incidence in Cameroonian prisons: A 1-year prospective study | |
J Noeske, N F Ndi, G Amougou Elo, S Mbondi Mfondih | 209-211 |
Continuing Medical Education
Spina bifida: A few simple facts about a complex condition | |
Graham Fieggen | 212 |
Spina bifida: A multidisciplinary perspective on a many-faceted condition | |
Graham Fieggen, K Fieggen, C Stewart, L Padayachy, J Lazarus, K Donald, S Dix-Peek, Z Toefy, A Figaji | 213-217 |
Aetiology and antenatal diagnosis of spina bifida | |
Karen Fieggen, Chantal Stewart | 218 |
Perinatal management of spina bifida | |
Llewellyn Padayachy, Dan Ochieng’ | 219 |
The paediatric neuropathic bladder | |
John Lazarus | 220 |
An approach to the developmental and cognitive profile of the child with spina bifida | |
Nerica Ramsundhar, Kirsty Donald | 221 |
CPD
CPD questionnaire | |
Progress towards the Millennium Development Goals
Progress towards the Millennium Development Goals in SA | |
Yogan Pillay, Peter Barron | 223 |
Successfully controlling malaria in South Africa | |
L Blumberg, J Frean, D Moonasar, South African Malaria Elimination Committee | 224-227 |
Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme | |
S A Madhi, L Bamford, N Ngcobo | 228-234 |
Laboratory information system data demonstrate successful implementation of the prevention of mother-to-child transmission programme in South Africa | |
G G Sherman, R R Lilian, S Bhardwaj, S Candy, P Barron | 235-238 |
Elimination of mother-to-child transmission of HIV in South Africa: Rapid scale-up using quality improvement | |
S Bhardwaj, P Barron, Y Pillay, L Treger-Slavin, P Robinson, A Goga, G Sherman | 239-243 |
Tuberculosis control in South Africa: Successes, challenges and recommendations | |
G J Churchyard, L D Mametja, L Mvusi, N Ndjeka, A C Hesseling, A Reid, S Babatunde, Y Pillay | 244-248 |
A brief history of South Africa's response to AIDS | |
N P Simelela, W D F Venter | 249-251 |